Galvin Roy 4
4 · HAEMONETICS CORP · Filed May 21, 2024
Insider Transaction Report
Form 4
Galvin Roy
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2024-05-17+2,872→ 7,410 total - Award
Non-qualified Stock Option (Right to Buy)
2024-05-17+6,313→ 6,313 totalExercise: $95.73Exp: 2031-05-17→ Common Stock (6,313 underlying)
Footnotes (4)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]This number includes unvested RSUs previously reported.
- [F4]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.